Company · founded 2007
Montana Molecular (United States)
Bozeman, United States · montanamolecular.com
- Citations, last 5 years
- 138
- Works, last 5 years
- 10
- h-index
- 28
- Scientists listed
- 0
- Grants since 2016
- 11
Grants received
2025–2026 · research · R43
Fluorescent Biosensors for measuring the signaling kinetics of GPCR ligands that activate G12/13 pathways.
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health
2019–2021 · research · R44
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health
2019 · research · R43
I-Corps Proposal for Commercialization of Live Cell Assays to Identify and Interrogate Stressed Neurons in Models of Neurodegenerative Disease
Kevin Matthew Harlen · Montana Molecular (United States) · funded by National Institutes of Health
2019–2023 · research · R44
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health
2019–2024 · research · R44
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Live Cell Assays to Identify and Interrogate Stressed Neurons in Models of Neurodegenerative Disease.
Kevin Matthew Harlen · Montana Molecular (United States) · funded by National Institutes of Health
2017–2021 · research · R44
A robust assay for detecting agonist bias in living cells.
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health
2017–2018 · research · R43
A robust assay for detecting agonist bias in living cells.
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health
2017–2022 · research · R44
A robust assay for detecting agonist bias in living cells.
Thomas E Hughes · Montana Molecular (United States) · funded by National Institutes of Health